Antitumor activity of interferon- β1a in hormone refractory prostate cancer with neuroendocrine differentiation

ConclusionsRecombinant IFN- β1a (Rebif) showed a potent in vitro anti-proliferative activity in androgen-resistant prostate cancer cells, and it could represent a promising tool for the treatment of this tumor.

Source: Journal of Endocrinological Investigation - February 28, 2017 Category: Endocrinology Source Type: research